CTEV Claritev Corporation
Healthcare$21.76+0.42%ClosedMarket Cap: $371.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-1.50
P/S
0.38
EV/EBITDA
9.55
DCF Value
$125.28
FCF Yield
-10.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.1%
Operating Margin
4.3%
Net Margin
-29.3%
ROE
205.8%
ROA
-5.9%
ROIC
0.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $244.7M | 26.4% | $6.7M | $-73.6M | $— | — |
| Q4 null | $246.6M | 68.4% | $8.7M | $-80.6M | $— | — |
| FY null | $965.4M | 27.6% | $45.1M | $-284.3M | $— | — |
| Q3 null | $246.0M | 74.8% | $10.1M | $-69.8M | $— | — |
| Q2 null | $241.6M | 74.8% | $16.6M | $-62.6M | $— | — |
| Q1 null | $231.3M | 73.9% | $9.7M | $-71.3M | $— | — |
| Q4 null | $232.1M | 75.4% | $-41.4M | $-138.0M | $— | — |
| FY null | $930.6M | 74.3% | $-1.39B | $-1.65B | $— | — |
| Q3 null | $230.5M | 73.6% | $-338.2M | $-391.4M | $— | — |
| Q2 null | $233.5M | 73.7% | $-523.9M | $-576.7M | $— | — |
| Q1 null | $234.5M | 74.4% | $-486.4M | $-539.7M | $— | — |
| Q4 2023 | $244.1M | 75.2% | $40.8M | $-31.4M | $-1.95 | — |